Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2016

Open Access 01-12-2016 | Research

Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation

Authors: Anne-Sophie Delesalle, Geoffroy Robin, Patricia Thomas-Desrousseaux, Didier Dewailly, Sophie Catteau-Jonard

Published in: Reproductive Biology and Endocrinology | Issue 1/2016

Login to get access

Abstract

Background

Oocyte donation is a medical technique used principally for woman with ovarian failure. Optimizing donor recruitment is essential to obtain the best results with this technique. Understanding how donor parameters influence outcome for the recipients is fundamental. The aim of this study was to determine whether clinical and/or biological parameters in the donors influence the chance of pregnancy in recipients. Our objective was also to verify whether the outcomes of controlled ovarian stimulation (COS) are predictive of pregnancy in the recipients.

Methods

A retrospective observational study was conducted in the Department of Reproductive Medicine in the Lille University Hospital. Between September 2005 and April 2014, COS was performed in 145 donors for 308 recipients’ cycles. We compared the cycles whose outcome was pregnancy to the cycles without pregnancy. Quantitative variables were compared using the nonparametric Mann–Whitney test. Qualitative variables were compared using a Chi-2 test or Fisher exact test, according to the numbers. Covariance analysis was performed to adjust for potential confounding factors.

Results

The donors who produced at least one pregnancy had a mean baseline serum anti-Müllerian hormone (AMH) level significantly higher than those who did not (p = 0.001). The mean antral follicle count did not differ between the 2 groups. After covariance analysis controlling for the number of couples attributed to a given donor, this difference remained significant (p = 0.029). Mature follicle number, estradiol serum level at the trigger day, number of mature oocytes and embryo number were significantly higher in the donors who produced pregnancy.

Conclusion

Serum AMH level is associated with pregnancy outcome after oocyte donation.
Literature
1.
go back to reference Barton SE, Missmer SA, Ashby RK, Ginsburg ES. Multivariate analysis of the association between oocyte donor characteristics, including basal follicle stimulating hormone (FSH) and age, and IVF cycle outcomes. Fertil Steril. 2010;94:1292–5.PubMedCrossRef Barton SE, Missmer SA, Ashby RK, Ginsburg ES. Multivariate analysis of the association between oocyte donor characteristics, including basal follicle stimulating hormone (FSH) and age, and IVF cycle outcomes. Fertil Steril. 2010;94:1292–5.PubMedCrossRef
2.
go back to reference Shulman A, Frenkel Y, Dor J, Levran D, Shiff E, Maschiach S. The best donor. Hum Reprod. 1999;14:2493–6.PubMedCrossRef Shulman A, Frenkel Y, Dor J, Levran D, Shiff E, Maschiach S. The best donor. Hum Reprod. 1999;14:2493–6.PubMedCrossRef
3.
go back to reference Wong IL, Legro RS, Lindheim SR, Paulson RJ, Sauer MV. Efficacy of oocytes donated by older women in an oocyte donation programme. Hum Reprod. 1996;11:820–3.PubMedCrossRef Wong IL, Legro RS, Lindheim SR, Paulson RJ, Sauer MV. Efficacy of oocytes donated by older women in an oocyte donation programme. Hum Reprod. 1996;11:820–3.PubMedCrossRef
4.
go back to reference Harris SE, Faddy M, Levett S, Sharma V, Gosden R. Analysis of donor heterogeneity as a factor affecting the clinical outcome of oocyte donation. Hum Fertil Camb Engl. 2002;5:193–8.CrossRef Harris SE, Faddy M, Levett S, Sharma V, Gosden R. Analysis of donor heterogeneity as a factor affecting the clinical outcome of oocyte donation. Hum Fertil Camb Engl. 2002;5:193–8.CrossRef
5.
go back to reference Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol. 2014;30:90–4.PubMedCrossRef Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol. 2014;30:90–4.PubMedCrossRef
6.
go back to reference La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.PubMedCrossRef La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–30.PubMedCrossRef
7.
go back to reference Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod. 2014;21(6):698–710.CrossRef Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod. 2014;21(6):698–710.CrossRef
8.
go back to reference Riggs R, Kimble T, Oehninger S, Bocca S, Zhao Y, Leader B, et al. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril. 2011;95:410–2.PubMedCrossRef Riggs R, Kimble T, Oehninger S, Bocca S, Zhao Y, Leader B, et al. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril. 2011;95:410–2.PubMedCrossRef
9.
go back to reference Bukulmez O, Li Q, Carr BR, Leader B, Doody KM, Doody KJ. Repetitive oocyte donation does not decrease serum anti-Müllerian hormone levels. Fertil Steril. 2010;94:905–12.PubMedCrossRef Bukulmez O, Li Q, Carr BR, Leader B, Doody KM, Doody KJ. Repetitive oocyte donation does not decrease serum anti-Müllerian hormone levels. Fertil Steril. 2010;94:905–12.PubMedCrossRef
10.
go back to reference Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, Sauer MV. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors. Reprod Biomed Online. 2010;20:42–7.PubMedCrossRef Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, Sauer MV. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors. Reprod Biomed Online. 2010;20:42–7.PubMedCrossRef
11.
go back to reference Talebian S, Licciardi F, Liu M, Grifo JA, Krey LC. Assessing anti-mullerian hormone (AMH) as a marker of ovarian response in anonymous oocyte donors: quantity or quality? Fertil Steril. 2008;90:S267.CrossRef Talebian S, Licciardi F, Liu M, Grifo JA, Krey LC. Assessing anti-mullerian hormone (AMH) as a marker of ovarian response in anonymous oocyte donors: quantity or quality? Fertil Steril. 2008;90:S267.CrossRef
12.
go back to reference Hazout A, Cohen Bacrie P, Mendoza R, Mendoza C, Tesarik J. Antimullerian Hormone, Ovarian Reserve and Oocyte Quality in Young Oocyte Donors. Fertil Steril. 2005;84:S251.CrossRef Hazout A, Cohen Bacrie P, Mendoza R, Mendoza C, Tesarik J. Antimullerian Hormone, Ovarian Reserve and Oocyte Quality in Young Oocyte Donors. Fertil Steril. 2005;84:S251.CrossRef
13.
go back to reference Polyzos NP, Stoop D, Blockeel C, Adriaensen P, Platteau P, Anckaert E, et al. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors. Reprod Biomed Online. 2012;24:532–9.PubMedCrossRef Polyzos NP, Stoop D, Blockeel C, Adriaensen P, Platteau P, Anckaert E, et al. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors. Reprod Biomed Online. 2012;24:532–9.PubMedCrossRef
14.
go back to reference Martínez F, Clua E, Carreras O, Tur R, Rodríguez I, Barri PN. Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors? Gynecol Endocrinol. 2013;29:754–7.PubMedCrossRef Martínez F, Clua E, Carreras O, Tur R, Rodríguez I, Barri PN. Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors? Gynecol Endocrinol. 2013;29:754–7.PubMedCrossRef
15.
go back to reference Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21:2022–6.PubMedCrossRef Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21:2022–6.PubMedCrossRef
16.
go back to reference Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150:166–70.PubMedCrossRef Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150:166–70.PubMedCrossRef
17.
go back to reference Irez T, Ocal P, Guralp O, Cetin M, Aydogan B, Sahmay S. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes. Arch Gynecol Obstet. 2011;284:1295–301.PubMedCrossRef Irez T, Ocal P, Guralp O, Cetin M, Aydogan B, Sahmay S. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes. Arch Gynecol Obstet. 2011;284:1295–301.PubMedCrossRef
18.
go back to reference Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98:1107–14.PubMedCrossRef Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. J Clin Endocrinol Metab. 2013;98:1107–14.PubMedCrossRef
19.
go back to reference Lin W-Q, Yao L-N, Zhang D-X, Zhang W, Yang X-J, Yu R. The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). J Assist Reprod Genet. 2013;30:649–55.PubMedPubMedCentralCrossRef Lin W-Q, Yao L-N, Zhang D-X, Zhang W, Yang X-J, Yu R. The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). J Assist Reprod Genet. 2013;30:649–55.PubMedPubMedCentralCrossRef
20.
go back to reference Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20:560–70.PubMedCrossRef Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20:560–70.PubMedCrossRef
Metadata
Title
Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation
Authors
Anne-Sophie Delesalle
Geoffroy Robin
Patricia Thomas-Desrousseaux
Didier Dewailly
Sophie Catteau-Jonard
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2016
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-016-0138-0

Other articles of this Issue 1/2016

Reproductive Biology and Endocrinology 1/2016 Go to the issue